“Roller-Coaster Budget” For NIH Criticized On Capitol Hill; $1 Billion Cut By FY 2000?
In Brief: Selection Of NCI Director Extended By Month; Fisher Named NSABP Scientific Director
SAIC Begins Transition Of Frederick Operations From Incumbent PRI
Managed Care Plans Seek Cost Efficacy, Not Research, Center Directors Warned
DCBDC Advisors Table Gl SPORE Over Pancreatic Cancer Research Requirement
DCE Board Approves Epidemiology Contract Recompetitions
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Michael Caputo appointed to President’s Cancer Panel
The cancer survivor and political operative says his appointment signals Trump’s interest in cancer, survivorship - The Galleri MCD vote: What FDA asked its advisors to ignore
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish
